Photolithography Advances; Updating Bioperl ; Data Collection Goes Mobile

PATENT WATCH | Photolithography Advances Affymetrix Affymetrix, the Santa Clara, Calif.-based manufacturer of GeneChip® microarrays, has developed a new device to create microarrays, according to a recently awarded patent.1 The new technique replaces physical photolithographic masks with computer-generated ones, and will, according to the application, "significantly improve the cost, quality, and efficiency of polymer array synthesis." GeneChip arrays typically consist of hundreds of th

Written byJeffrey Perkel
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

PATENT WATCH | Photolithography Advances

Affymetrix, the Santa Clara, Calif.-based manufacturer of GeneChip® microarrays, has developed a new device to create microarrays, according to a recently awarded patent.1 The new technique replaces physical photolithographic masks with computer-generated ones, and will, according to the application, "significantly improve the cost, quality, and efficiency of polymer array synthesis."

GeneChip arrays typically consist of hundreds of thousands of 25-base-long oligonucleotide probes. These probes are synthesized on-chip, in parallel, using a process that employs photoreactive nucleotide building blocks. When exposed to light, these precursors become "deprotected," meaning they are available for coupling to the next nucleotide in the chain. Affymetrix (www.affymetrix.com) employs photomasks--small wafers riddled with holes-- to selectively illuminate, and thereby deprotect, different regions of the array that are to react with the next added nucleotide. In this way, each probe can be synthesized with a unique sequence.

The new process replaces the old ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo